Home › Stocks › LBRX › All Fund Holders
LBRX — LB PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 29 · Reported value held: $281.10M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 2.73M | $88.74M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 1.50M | $48.87M | 0.01% | New |
| Balyasny Asset Management history | Q2 2026 | 921.47K | $29.91M | 0.04% | Hold |
| Vanguard Group history | Q4 2025 | 1.11M | $24.77M | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 612.79K | $19.89M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 576.46K | $18.71M | 0.01% | Add |
| Millennium Management history | Q2 2026 | 259.22K | $8.41M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 215.97K | $7.01M | 0.01% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 195.49K | $6.34M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 188.91K | $6.13M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 186.04K | $6.04M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 85.95K | $2.79M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2026 | 58.89K | $1.91M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 54.98K | $1.78M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 51.21K | $1.66M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 65.43K | $1.61M | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 48.65K | $1.58M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 26.54K | $861.36K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 21.97K | $713.21K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 19.54K | $634.07K | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 15.72K | $510.16K | 0.00% | Add |
| Norges Bank Investment Management history | Q4 2025 | 20.00K | $445.20K | 0.00% | New |
| D. E. Shaw & Co history | Q2 2026 | 13.52K | $438.73K | 0.00% | New |
| Marshall Wace history | Q4 2025 | 18.01K | $400.99K | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 12.00K | $389.49K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 9.84K | $319.29K | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 6.25K | $202.91K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 276 | $8.96K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 18.62K | $605 | 0.00% | Add |